Ryan Savitz

Ryan Savitz

Executive Vice President, Chief Financial Officer, Chief Business Officer and TreasureratDianthus Therapeutics, Inc. /DE/· In proxies 2023–2025

Pay in FY2025+27% from the year before · Dianthus Therapeutics, Inc. /DE/ stock +89.0% the same year

Ryan Savitz was paid $5.1M in FY2025 (Dec), up 27%. Dianthus Therapeutics, Inc. /DE/ stock rose 89.0% that year.

Pay$100 in the stock at the end of FY22 → $652
Pay is from the Summary Compensation Table of each Dianthus Therapeutics, Inc. /DE/ proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Dianthus Therapeutics, Inc. /DE/Public company · 3 yr
    • Executive Vice President, Chief Financial Officer, Chief Business Officer and Treasurer2023 – Present · 3 yrStock in role +1,290%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?